Incannex healthcare inc. reports fiscal full year 2024 financial results and business updates

New york and melbourne, australia, sept. 30, 2024 (globe newswire) -- incannex healthcare inc. (nasdaq: ixhl), (incannex), a clinical-stage biopharmaceutical company developing innovative medicines for people with serious chronic diseases and significant unmet medical needs, today reported fiscal full year financial results and provided business updates.
IXHL Ratings Summary
Quant
IXHL Quant Ranking
Sector
Industry
Quant Rating
Quant Score